Video | NWR Virtual Healthcare Conference

Avecho CEO Dr Paul Gavin recently presented at the NWR Virtual Healthcare Conference.

Dr Gavin spoke of the opportunities that Avecho is pursuing with its TPM®-enhanced CBD capsule, including the Company’s upcoming Phase III trial, and its ambitions to seek TGA registration.

Dr Gavin said:

“When the TGA released its guidance [on over-the-counter CBD products] it was like it was written specifically for us. It plays to all our strengths and all the things that we have been developing over the last 20 years. It's a really unique commercial opportunity that we felt we had to take advantage of because any CBD products registered with the TGA for this will command a unique commercial opportunity in Australia.”